Kadonosono K, Matsumoto S, Uchio E, Sugita M, Akura J, Ohno S
Department of Ophthalmology, Yokohama City University Medical Center, Japan.
Ophthalmic Surg Lasers. 2001 Jan-Feb;32(1):19-24.
To analyze the incidence of iris neovascularization after vitrectomy combined with phacoemulsification and intraocular lens (IOL) implantation using a small incision in the treatment of proliferative diabetic retinopathy (PDR).
We studied a consecutive series of 46 eyes in which vitrectomy combined with phacoemulsification and IOL implantation had been performed, and compared the surgical results with a prior series of 40 eyes in which vitrectomy alone had been performed.
Postoperative iris and angle neovascularization was found in 6 eyes (15%) treated by vitrectomy alone, but in only 1 eye (2%) treated by combined vitrectomy (P<0.05). Final visual acuity improved by two or more lines in 23 eyes (57%) in the vitrectomy alone group, and in 35 eyes (76%) in the combined vitrectomy group.
The incidence of postoperative rubeosis iridis was significantly lower, and the visual results were satisfactory with vitrectomy combined with phacoemulsification and IOL implantation for PDR. These findings suggest that combined vitrectomy for PDR is a useful surgical procedure.
分析采用小切口玻璃体切除术联合超声乳化白内障吸除及人工晶状体（IOL）植入术治疗增殖性糖尿病视网膜病变（PDR）后虹膜新生血管的发生率。
我们研究了连续46只接受玻璃体切除术联合超声乳化白内障吸除及IOL植入术的患眼，并将手术结果与先前连续40只仅接受玻璃体切除术的患眼进行比较。
仅接受玻璃体切除术治疗的6只眼（15%）出现术后虹膜及房角新生血管，而接受联合玻璃体切除术治疗的仅1只眼（2%）出现（P<0.05）。仅接受玻璃体切除术组中23只眼（57%）最终视力提高两行或更多行，联合玻璃体切除术组中35只眼（76%）最终视力提高两行或更多行。
对于PDR，采用玻璃体切除术联合超声乳化白内障吸除及IOL植入术，术后虹膜红变的发生率显著降低，视觉效果令人满意。这些发现表明，联合玻璃体切除术治疗PDR是一种有效的手术方法。
Zotero 插件